GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

LND-2

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Hangzhou Dingyan Chem Co., LTD	0571-87157530-8007 13868066926	sales@dingyanchem.com	China	2190	58
Chengdu Push Bio-Technology Co., Ltd.	028-85370565-229 18080489829	3004654993@qq.com	China	8902	60
BOC Sciences	16314854226	inquiry@bocsci.com	United States	9713	58
Wuhan Tangzhi Pharmaceutical Co., Ltd.	0532-88500810 13658392159	sale@glycogene.com	China	837	58
Chengdu Push Bio-Technology Co., Ltd.	18080489829	3004654993@qq.com	China	9209	58
Shanghai Yingxin Laboratory Equipment Co., Ltd.	021-021-59178156 17002132182	3146474380@qq.com	China	11603	58
WEITIXIHAUGONG	0371-53370800 18037197114	2853031799@qq.com	China	10110	58
ShenZhen Trendseen Biological Technology Co.,Ltd.	13417589054 13417589054	trendseenbio@gmail.com	China	9470	58

62258-12-2()Verwandte Suche:

---

• lacto-n-difucohexoseii
• LACTO-N-DIFUCOHEXAOSE II FROM*HUMAN MILK
• β-d-gal-(1→3)-[α-l-fuc-(1→4)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-[α-l-fuc-(1→3)]-d-glc
• Lacto-N-difucopentaose II
• N-[(2R,3R,4R,5S,6R)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3R,4R,5R)-1,2,5-trihydroxy-6-oxo-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-hexan-3-yl]oxy-oxan-4-yl]oxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyl-oxan-2-yl]oxy-oxan-3-yl]acetamide
• LNH, β-D-Gal-(1-3)-[α-L-Fuc-(1-4)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc
• Lacto-N-difucohexaose II ,95%
• LACTO-N-DIFUCOHEXAOSE-2
• LACTO-N-DIFUCOSYLHEXAOSE II
• LACTO-N-DIFUCOHEXAOSE II
• LDFH II
• LND-2
• LNDFH II
• BETA-D-GAL-[1->3]-(ALPHA-L-FUC-[1->4])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-D-GLC
• GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC
• Lacto-N-difucohexaose II(Lewisa hexaose)(LNDFH-II)
• D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→4)-O-[β-D-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-O-[6-deoxy-α-L-galactopyranosyl-(1→3)]-
• Lewis a (Lea) hexaose
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on BSA
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT B)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin (Linker-BT C)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin and fluorescein (Linker-BT-FLUO A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to biotin and stearic chain (Linker-BT-STEA A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on CRM197
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with DBCO (Linker-DBCO A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to desthiobiotin (Linker-DBT-A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to fluorescein (Linker-FLUO A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on gel for affinity chromatography (Linker-GEL A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on gel for affinity chromatography (Linker-GEL B)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on HSA
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on KLH
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with cyclic di-thiol (Linker-LIPO A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) linked to maleimide (Linker-MAL A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal azide (Linker-N3 A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal azide (Linker-N3 B)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 A) Hydrochloride form
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 B)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 C)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with free terminal amine (Linker-NH2 D)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) grafted on OVA
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with customizable dual functionalization
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with stearic chain (Linker-STEA A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH A)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH B)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) with terminal alkyne (Linker-CΞCH C)
• Lacto-N-difucohexaose II (Le a hexa)
• Lewis a (Lea) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR)
• 62258-12-2
• Carbohydrate Analysis
• Carbohydrates
• Carbohydrate Standards
• Biochemicals and Reagents
• BioChemical
• Oligosaccharide
• Post-translational Modification
• Proteomics and Protein Expression
• Proteomics